Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 37

    1.

    Risk perception for developing diabetes among pharmacists.

    Pinelli NR, Berlie HD, Slaughter RL, Jaber LA.

    Ann Pharmacother. 2009 Jun;43(6):1050-6. Epub 2009 May 12.PMID: 19435966 [PubMed - indexed for MEDLINE]Related articles

    2.

    Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.

    Pinelli NR, Cha R, Brown MB, Jaber LA.

    Ann Pharmacother. 2008 Nov;42(11):1541-51. Epub 2008 Oct 28.PMID: 18957626 [PubMed - indexed for MEDLINE]Related articles

    3.

    Health issues in the Arab American community. The use of glucose-lowering agents and aspirin among Arab Americans with diabetes.

    Berlie HD, Hammad A, Jaber LA.

    Ethn Dis. 2007 Summer;17(2 Suppl 3):S3-42-S3-45.PMID: 17985450 [PubMed - indexed for MEDLINE]Related articles

    4.

    Quality of diabetes care in Arab Americans.

    Berlie HD, Herman WH, Brown MB, Hammad A, Jaber LA.

    Diabetes Res Clin Pract. 2008 Feb;79(2):249-55. Epub 2007 Oct 18.PMID: 17949846 [PubMed - indexed for MEDLINE]Related articles

    5.

    For the patient. Diabetes and its risk factors among Chaldean Americans.

    Kridli SA, Herman WH, Brown MB, Fakhouri H, Jaber LA.

    Ethn Dis. 2006 Spring;16(2):588. No abstract available. PMID: 17682267 [PubMed - indexed for MEDLINE]Related articles

    6.

    The epidemiology of diabetes and its risk factors among Chaldean Americans.

    Kridli SA, Herman WH, Brown MB, Fakhouri H, Jaber LA.

    Ethn Dis. 2006 Spring;16(2):351-6.PMID: 17682235 [PubMed - indexed for MEDLINE]Related articles

    7.

    Evolution of peroxisome proliferator-activated receptor agonists.

    Chang F, Jaber LA, Berlie HD, O'Connell MB.

    Ann Pharmacother. 2007 Jun;41(6):973-83. Epub 2007 May 22. Review.PMID: 17519293 [PubMed - indexed for MEDLINE]Related articles

    8.

    Thiazolidinediones and the risk of edema: a meta-analysis.

    Berlie HD, Kalus JS, Jaber LA.

    Diabetes Res Clin Pract. 2007 May;76(2):279-89. Epub 2006 Oct 18.PMID: 17055103 [PubMed - indexed for MEDLINE]Related articles

    9.

    The epidemiology of diabetes and its risk factors among Chaldean Americans.

    Kridli SA, Herman WH, Brown M, Fakhouri H, Jaber LA.

    Ethn Dis. 2005 Winter;15(1 Suppl 1):S1-30-1. No abstract available. PMID: 15787040 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cardiovascular risk factors in an Arab-American population in southeastern Michigan.

    Hammad A, Herman WH, Jaber LA.

    Ethn Dis. 2005 Winter;15(1 Suppl 1):S1-29. No abstract available. PMID: 15787039 [PubMed - indexed for MEDLINE]Related articles

    11.

    Diabetes and the metabolic syndrome in Arab Americans: a community-based sample.

    Jaber LA.

    Ethn Dis. 2005 Winter;15(1 Suppl 1):S1-26-8. No abstract available. PMID: 15787038 [PubMed - indexed for MEDLINE]Related articles

    12.

    The prevalence of the metabolic syndrome among arab americans.

    Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH.

    Diabetes Care. 2004 Jan;27(1):234-8.PMID: 14693995 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Lack of acculturation is a risk factor for diabetes in arab immigrants in the US.

    Jaber LA, Brown MB, Hammad A, Zhu Q, Herman WH.

    Diabetes Care. 2003 Jul;26(7):2010-4.PMID: 12832304 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Barriers and strategies for research in Arab Americans.

    Jaber LA.

    Diabetes Care. 2003 Feb;26(2):514-5. No abstract available. PMID: 12547891 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Epidemiology of diabetes among Arab Americans.

    Jaber LA, Brown MB, Hammad A, Nowak SN, Zhu Q, Ghafoor A, Herman WH.

    Diabetes Care. 2003 Feb;26(2):308-13.PMID: 12547854 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Aspirin dose for prevention of cardiovascular disease in diabetics.

    Nowak SN, Jaber LA.

    Ann Pharmacother. 2003 Jan;37(1):116-21. Review.PMID: 12503945 [PubMed - indexed for MEDLINE]Related articles

    17.

    Pioglitazone: effect on CYP3A4 activity.

    Nowak SN, Edwards DJ, Clarke A, Anderson GD, Jaber LA.

    J Clin Pharmacol. 2002 Dec;42(12):1299-302.PMID: 12463723 [PubMed - indexed for MEDLINE]Related articles

    18.

    Metabolic control and adherence to american diabetes association practice guidelines in a pharmacist-managed diabetes clinic.

    Nowak SN, Singh R, Clarke A, Campbell E, Jaber LA.

    Diabetes Care. 2002 Aug;25(8):1479. No abstract available. PMID: 12145256 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Insulin-metformin combination therapy in obese patients with type 2 diabetes.

    Jaber LA, Nowak SN, Slaughter RR.

    J Clin Pharmacol. 2002 Jan;42(1):89-94.PMID: 11808829 [PubMed - indexed for MEDLINE]Related articles

    20.

    Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.

    Sonnenberg GE, Garg DC, Weidler DJ, Dixon RM, Jaber LA, Bowen AJ, DeChemey GS, Mullican WS, Stonesifer LD.

    Ann Pharmacother. 1997 Jun;31(6):671-6.PMID: 9184703 [PubMed - indexed for MEDLINE]Related articles

    21.

    Diabetes management: follow-up.

    Halapy H, Jaber LA.

    Ann Pharmacother. 1997 Mar;31(3):371. No abstract available. PMID: 9066949 [PubMed - indexed for MEDLINE]Related articles

    22.

    The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.

    Jaber LA, Ducharme MP, Edwards DJ, Slaughter RL, Grunberger G.

    Pharmacotherapy. 1996 Sep-Oct;16(5):760-8.PMID: 8888072 [PubMed - indexed for MEDLINE]Related articles

    23.

    Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitus.

    Jaber LA, Antal EJ, Welshman IR.

    Ann Pharmacother. 1996 May;30(5):472-5.PMID: 8740326 [PubMed - indexed for MEDLINE]Related articles

    24.

    Evaluation of a pharmaceutical care model on diabetes management.

    Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H.

    Ann Pharmacother. 1996 Mar;30(3):238-43.PMID: 8833557 [PubMed - indexed for MEDLINE]Related articles

    25.

    The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.

    Jaber LA, Ducharme MP, Halapy H.

    Ther Drug Monit. 1996 Feb;18(1):6-13.PMID: 8848822 [PubMed - indexed for MEDLINE]Related articles

    26.

    Metformin: an antihyperglycemic agent for treatment of type II diabetes.

    Melchior WR, Jaber LA.

    Ann Pharmacother. 1996 Feb;30(2):158-64. Review.PMID: 8835050 [PubMed - indexed for MEDLINE]Related articles

    27.

    Peripheral diabetic neuropathy: current concepts in treatment.

    Calissi PT, Jaber LA.

    Ann Pharmacother. 1995 Jul-Aug;29(7-8):769-77. Review.PMID: 8520095 [PubMed - indexed for MEDLINE]Related articles

    28.

    Diabetes and related metabolic risk factors among Arab Americans.

    Jaber LA, Slaughter RL, Grunberger G.

    Ann Pharmacother. 1995 Jun;29(6):573-6.PMID: 7663027 [PubMed - indexed for MEDLINE]Related articles

    29.

    Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM.

    Jaber LA, Antal EJ, Slaughter RL, Welshman IR.

    Diabetes Care. 1994 Nov;17(11):1300-6.PMID: 7821171 [PubMed - indexed for MEDLINE]Related articles

    30.

    The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy.

    Jaber LA, Lewis NJ, Slaughter RL, Neale AV.

    J Clin Pharmacol. 1993 Mar;33(3):239-45.PMID: 8463437 [PubMed - indexed for MEDLINE]Related articles

    31.

    Angiotensin-converting enzyme inhibitors in diabetic nephropathy.

    Melchior WR, Bindlish V, Jaber LA.

    Ann Pharmacother. 1993 Mar;27(3):344-50. Review.PMID: 8384031 [PubMed - indexed for MEDLINE]Related articles

    32.

    The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics.

    Jaber LA, Antal EJ, Slaughter RL, Welshman IR.

    Eur J Clin Pharmacol. 1993;45(5):459-63.PMID: 8112376 [PubMed - indexed for MEDLINE]Related articles

    33.

    Possible correlation between glycemia and blood pressure in black, diabetic, hypertensive patients.

    Jaber LA, Melchior WR, Rutledge DR.

    Ann Pharmacother. 1992 Jul-Aug;26(7-8):882-6.PMID: 1504392 [PubMed - indexed for MEDLINE]Related articles

    34.

    An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.

    Jaber LA, Wenzloff NJ, Komanicky P, Antal EJ.

    J Clin Pharmacol. 1990 Feb;30(2):181-8.PMID: 2107214 [PubMed - indexed for MEDLINE]Related articles

    35.

    Enoxacin: a new fluoroquinolone.

    Jaber LA, Bailey EM, Rybak MJ.

    Clin Pharm. 1989 Feb;8(2):97-107. Review.PMID: 2645085 [PubMed - indexed for MEDLINE]Related articles

    36.

    Glycosylated hemoglobin levels and self-reported stress in adults with diabetes.

    Demers RY, Neale AV, Wenzloff NJ, Gronsman KJ, Jaber LA.

    Behav Med. 1989 Winter;15(4):167-72.PMID: 2597780 [PubMed - indexed for MEDLINE]Related articles

    37.

    Oral methoxsalen photochemotherapy of extensive pityriasis alba. Preliminary report.

    Zaynoun S, Jaber LA, Kurban AK.

    J Am Acad Dermatol. 1986 Jul;15(1):61-5.PMID: 3722511 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...